Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity

Oral Oncology

Volumn 41, Issue 4, 2005, Pages 423-428

  Sirianni, Nicky ^a   Wang, Jun ^a   Ferris, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Antiviral therapy; Head and neck cancer; Human papillomavirus

Indexed keywords

CIDOFOVIR; PROTEIN P53;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSCRIPTION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION;

EID: 15244363807     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.11.003     Document Type: Article

References (24)

1. R.T. Greenlee, M.B. Hill-Harmon, T. Murray, and M. Thun Cancer statistics, 2001 CA Cancer J Clin 51 1 2001 15 36
2. M.L. Gillison, W.M. Koch, and R.B. Capone Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 2000 709 720
3. L.D. Ke, K. Adler-Storthz, M.F. Mitchell, G.L. Clayman, and Z. Chen Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines Oral Oncol 1999 415 420
4. B.M. Steinberg, and T.P. DiLorenzo A possible role for human papillomaviruses in head and neck cancer Cancer Metastasis Rev 1996 91 112
5. M. Scheffner, K. Munger, J.C. Byrne, and P.M. Howley The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines Proc Natl Acad Sci USA 88 13 1991 5523 5527
6. K. Smith-McCune, D. Kalman, C. Robbins, S. Shivakumar, L. Yuschenkoff, and J.M. Bishop Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130 Proc Natl Acad Sci USA 96 12 1999 6999 7004
7. M.L. Gillison, and K.V. Shah Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers Curr Opin Oncol 2001 183 188
8. M. Dai, G.M. Clifford, and F. leCalvez Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study Cancer Res 2004 468 471
9. C.C. Ragin, S.C. Reshmi, and S.M. Gollin Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line Int J Cancer 2004 701 709
10. K. Lindel, K.T. Beer, J. Laissue, R.H. Greiner, and D.M. Aebersold Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma Cancer 2001 805 813
11. B. Abdulkarim, S. Sabri, and E. Deutsch Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers Oncogene 2002 2334 2346
12. E. De Clercq Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections Verh K Acad Geneeskd Belg 58 1 1996 19 47 [discussion 47-9]
13. X. Xiong, J.L. Smith, and M.S. Chen Effect of incorporation of Cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation Antimicrob Agents Chemother 41 3 1997 594 599
14. J.A. Johnson, and J.D. Gangemi Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2- (phosphonylmethoxy)propyl]cytosine Antimicrob Agents Chemother 43 5 1999 1198 1205
15. G. Andrei, R. Snoeck, J. Piette, P. Delvenne, and E. De Clercq Inhibiting effects of Cidofovir (HPMPC) on the growth of the human cervical carcinoma (SiHa) xenografts in athymic nude mice Oncol Res 10 10 1998 533 539
16. G. Andrei, R. Snoeck, J. Piette, P. Delvenne, and E. De Clercq Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines Oncol Res 10 10 1998 523 531
17. E. De Clercq, G. Andrei, and J. Balzarini Antitumor potential of acyclic nucleoside phosphonates Nucleosides Nucleotides 18 4-5 1999 759 771
18. E. Van Cutsem, R. Snoeck, and M. Van Ranst Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine J Med Virol 45 2 1995 230 235
19. B.L. Petersen, C. Buchwald, J. Gerstoft, P. Bretlau, and H. Lindeberg An aggressive and invasive growth of juvenile papillomas involving the total respiratory tract J Laryngol Otol 112 11 1998 1101 1104
20. R. Snoeck, W. Wellens, and C. Desloovere Treatment of severe laryngeal papillomatosis with intralesional injections of Cidofovir [(S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine] J Med Virol 54 3 1998 219 225
21. C.C. Ragin, S.C. Reshmi, and S.M. Gollin Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line Int J Cancer 110 5 2004 701 709
22. S.D. Vernon, E.R. Unger, D.L. Miller, D.R. Lee, and W.C. Reeves Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer Int J Cancer 74 1 1997 50 56
23. F. Wang-Johanning, D.W. Lu, Y. Wang, M.R. Johnson, and G.L. Johanning Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis Cancer 94 8 2002 2199 2210
24. S. Jeon, B.L. Allen-Hoffmann, and P.F. Lambert Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells J Virol 69 5 1995 2989 2997